Cross-sectional research on QOL of hematopoietic stem cell transplant patient families
Not Applicable
- Conditions
- Family of patients undergoing hematopoietic stem cell transplantation
- Registration Number
- JPRN-UMIN000047466
- Lead Sponsor
- Toranomon Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patient families that the attending physician deems inappropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Caregiver Quality of Life Index-Cancer
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence QOL in hematopoietic stem cell transplant patient families?
How does psychosocial intervention compare to standard care for family QOL post-hematopoietic stem cell transplant?
What biomarkers correlate with improved QOL outcomes in HSCT family caregivers?
What adverse events are associated with HSCT family QOL and how are they managed?
Are there combination therapies that enhance QOL for families of HSCT recipients with specific hematologic malignancies?